DavidAMcLainMDFACP, MACR, FRCP(He/Him)
Rheumatology • Birmingham, ALMcLain Medical Associates, P.C., Symposium Director, Congress of Clinical Rheumatology, Destin and San Diego
Dr. McLain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2229 Cahaba Valley DR
Birmingham, AL 35242Phone+1 205-991-8996Fax+1 205-991-8997- Is this information wrong?
Summary
- David McLain, MD, FACP, MACR, FRCP, BA from Northwestern, MD (honors) from Tulane in New Orleans. At Barnes/Wash. U in StL he was a resident and Rheum fellow. He was Chief of Rheum at Brookwood. He originated the Congress of Clinical Rheumatology, second largest rheum meeting in the U.S. Past Pres. of the AL Soc. for the Rheum. Dis. now Exec. Dir. In 2021, the American College of Rheumatology gave him the Master designation, the highest honor awarded by the College. In 2023, he was made a Fellow of the Royal College of Physicians, London, England.
Clinical Expertise
- Principal Investigator, Rheumatoid arthritis, Systemic lupus erythematosus, Sjogren's syndrome, Psoriatic arthritis, Gout, Fibromyalgia, Hashimoto's thyroiditis, Ankylosing spondylitis, Osteoporosis, Osteoarthritis, Reactive arthritis, Systemic Scleroderma, Arthritis, Submersion injury
Education & Training
International Society for Clinical DensitometryC.C.D, Clinical, Densitometry, 2002 - 2002
Washington University/B-JH/SLCH ConsortiumFellowship, Rheumatology, 1977 - 1979- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1975 - 1977
Ochsner Clinic FoundationInternship, Internal Medicine, 1974 - 1975
Tulane University School of MedicineClass of 1974
Northwestern UniversityBA, Psychology, Premed, 1966 - 1970
Certifications & Licensure
AL State Medical License 1981 - 2024
LA State Medical License 1974 - 1977- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow Royal College of Physicians (London, England), 2023
- Master (MACR) American College of Rheumatology
- Patients’ Choice Award winner vitals.com, 2011-2018
- Join now to see all
Clinical Trials
- Study of Flavocoxid (Limbrel) Versus Naproxen in Subjects With Moderate-Severe Osteoarthritis of the Knee Start of enrollment: 2006 Mar 01
Publications & Presentations
PubMed
- 3 citationsMissing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain.Roy D Altman, Robert W Ike, Max I Hamburger, David A McLain, Michael J Daley, Thomas C Adamson 3rd> ;The Journal of Rheumatology. 2022 Aug 1
- 142 citationsThe use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic painJarred Younger, Luke Parkitny, David A. McLain> ;Clinical Rheumatology. 2014 Feb 15
- Three new point mutations in type II procollagen (COL2A1) and identification of a fourth family with the COL2A1 Arg519-->Cys base substitution using conformation sensi...Williams, C. J., Rock, M., Considine, E., McCarron, S., Gow, P., Ladda, R., McLain, D., Michels, V. M., Murphy, W., Prockop, D. J.> ;Hum Mol Genet. 1995 Feb
- Join now to see all
Journal Articles
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic painJarred Younger, Luke Parkitny, David McLain, Clinical Rheumatology, 2/2014
- Medicine does not exist in a Vacuum.McLain, DA, MASA Review, 1: 23-25
- Current trends in the Diagnosis and Treatment of Chronic Neuromuscular Pain Syndromes: Myofascial Pain Syndrome, Chronic Tension-Type Headache, and Fibromyalgia.Jay, GW, Krusz, JC, Longmire, DR, McLain, DA, The American Academy of Pain Management
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Colchicine and PseudogoutMcLain, DA, Spilberg, l, Berney, S. Simchowitz, L, Arthritis and Rheumatism, 23: 718
- An HLA Public Antigen is More Common than HLA B27 in Patients with Ankylosing Spondylitis.McLain, DA, Luehrman, LK, Rodey, GE, Schwartz, BD, Arthritis and Rheumatism, 23: 718
- HLA Public Antigen is More Common than HLA B27 in Patients with Ankylosing Spondylitisn, in Preud'Homme and Hawken.McLain, DA, Luehrman, LK, Rodey, GE, Schwartz, BD, 4th International Congress of Immunology, Paris
- Join now to see all
Authored Content
- A Vast Array of Eye-Opening Studies Were Featured at ACR 2022November 2022
- Commentary on Manzi Lupus articleJuly 2019
- Commentary on Filgotinib in RA articleJuly 2019
- Commentary on EULAR Gout guidelinesJuly 2019
- Commentary on Ankylosing Spondylitis and use of OpioidsJune 2019
- Commentary on Stem Cell ClinicsJune 2019
- Commentary on Steroid use in GCA and PMR and infection riskJune 2019
- Commentary on Barriers to control of RAJune 2019
- Commentary on when to stop medications in unplanned pregnanciesJune 2019
- Join now to see all
Press Mentions
Quick Facts About Fibromyalgia and Related DiseasesJanuary 14th, 2017
Research History
- Principal Investigator, Achieve Clinical Research, LLC--rheumatoid arthritis, osteoporosis, osteoarthritis, lupus, psoriatic arthritis, fibromyalgia2008 - 2014
Professional Memberships
- Fellow
- United RheumatologyMember
- Member
- Alabama Society for the Rheumatic Diseases (ASRD)Executive Director
- Member
- Medical Association of the States of Alabama (MASA)Member
- Jefferson County Medical SocietyMember
- Royal College of Physicians, LondonFellow
Hospital Affiliations
Grandview Medical CenterBirmingham, Alabama
Ascension St. Vincent's BirminghamBirmingham, Alabama
Brookwood Baptist Medical CenterBirmingham, Alabama
External Links
- Fibromyalgia Updatehttps://www.youtube.com/watch?v=7XSqUBiil-k&feature=youtu.be
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
